Skip to main content
Download PDF
- Main
Transaminitis from Duloxetine: Case Report
© 2026 by the author(s). Learn more.
Published Web Location
https://doi.org/10.5811/cpcem.61865Abstract
Introduction: Duloxetine, a serotonin-norepinephrine reuptake inhibitor, is commonly prescribed for depression, anxiety, and neuropathic pain. Although rare, duloxetine has been associated with hepatotoxicity.
Case Report: We present the case of a 61-year-old male with multiple comorbidities who developed significant transaminitis two months after initiation of duloxetine therapy.
Conclusion: Emergency physicians should be cognizant of duloxetine-induced liver injury, particularly in patients with increased risk factors who present with unexplained liver injury.